Supplement: Therapeutic Cancer Vaccine Roundup
Individualized Cell Therapies Come with a Unique Set of Bioprocess Requirements
Supplement: Circumventing Cancer Cells’ Defenses
Cancer Cells Can Exploit Well-Evolved Moves to Evade Immune Detection
Smelly Camel Urine Finding Could Lead to Novel Therapies for Sleeping Sickness
Sounds of Science Podcast
Supplement: Treating “Solid” Tumors with CAR T Cells
The Road to Developing Effective Cancer Immunotherapies Using CAR T Cells Has Been a Long and Sometimes Rocky One
For full access to this article login to GEN Select now.
Getting a Handle on Nanobiotech Products
Regulators and Companies Are Laying the Groundwork for a Predicted Bright Future
- As the regulatory pathway to approval for biotech products becomes more arduous, lengthy, and expensive, biofirms are fighting to keep pace with a rapidly changing regulatory landscape. They also are trying to find out how the FDA is going to look at nanotechnology product development. A number of biotech ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.